Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis

RAC Siemieniuk, JJ Bartoszko, JPD Martinez, E Kum… - Bmj, 2021 - bmj.com
Objective To evaluate the efficacy and safety of antiviral antibody therapies and blood
products for the treatment of novel coronavirus disease 2019 (covid-19). Design Living …
被引用次数：99 相关文章

Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis

RAC Siemieniuk, JJ Bartoszko… - BMJ: British Medical …, 2021 - search.proquest.com
Objective To evaluate the efficacy and safety of antiviral antibody therapies and blood
products for the treatment of novel coronavirus disease 2019 (covid-19). Design Living …

Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis

RA Siemieniuk, JJ Bartoszko… - BMJ (Clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Objective To evaluate the efficacy and safety of antiviral antibody therapies and blood
products for the treatment of novel coronavirus disease 2019 (covid-19). Design Living …

Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis

RAC Siemieniuk, JJ Bartoszko, JPD Martinez, E Kum… - 2021 - open.library.ubc.ca
OBJECTIVE To evaluate the efficacy and safety of antiviral antibody therapies and blood
products for the treatment of novel coronavirus disease 2019 (covid-19). DESIGN Living …
[HTML] nih.gov

[HTML][HTML] Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis

RAC Siemieniuk, JJ Bartoszko, JPD Martinez, E Kum… - The BMJ, 2021 - ncbi.nlm.nih.gov
Objective To evaluate the efficacy and safety of antiviral antibody therapies and blood
products for the treatment of novel coronavirus disease 2019 (covid-19). Design Living …

Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis.

RA Siemieniuk, JJ Bartoszko, DM JP… - … (Clinical Research ed …, 2021 - europepmc.org
Objective To evaluate the efficacy and safety of antiviral antibody therapies and blood
products for the treatment of novel coronavirus disease 2019 (covid-19). Design Living …
[HTML] bmj.com

[HTML][HTML] Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis

RAC Siemieniuk, JJ Bartoszko, JPD Martinez, E Kum… - BMJ, 2021 - bmj.com
Objective To evaluate the efficacy and safety of antiviral antibody therapies and blood
products for the treatment of novel coronavirus disease 2019 (covid-19). Design Living …

Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis.

RA Siemieniuk, JJ Bartoszko, DM JP… - … (Clinical Research ed …, 2021 - europepmc.org
Objective To evaluate the efficacy and safety of antiviral antibody therapies and blood
products for the treatment of novel coronavirus disease 2019 (covid-19). Design Living …

Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis

RAC Siemieniuk, JJ Bartoszko, JPD Martinez, E Kum… - 2021 - open.library.ubc.ca
OBJECTIVE To evaluate the efficacy and safety of antiviral antibody therapies and blood
products for the treatment of novel coronavirus disease 2019 (covid-19). DESIGN Living …